DEADLINE ALERT for TUYA, LFST,

0

LOS ANGELES, Aug. 26, 2022 (GLOBE NEWSWIRE) — The law firm of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly traded companies. Investors have until the deadlines listed below to file as lead plaintiff.

Investors experiencing losses on their investments are encouraged to contact the law offices of Frank R. Cruz to discuss their legal rights in these class action lawsuits at 310-914-5007 or by email at [email protected].

Tuya Inc. (:TUYA)
Course period: March 15, 2021 – August 9, 2022
Lead Applicant Deadline: October 11, 2022

The complaint filed in this class action alleges that the defendants made materially false and/or misleading statements, and failed to disclose material adverse facts regarding the company’s business, operations and prospects. Specifically, defendants failed to disclose to investors: (1) that a significant portion of Tuya’s China-based customers were engaged in the widespread and systematic manipulation of product reviews and offerings in violation of Tuya’s Terms of Service; ‘Amazon.com; (2) that prior to the IPO, a consumer investigation and data breach revealed an illicit fake review scheme perpetrated by many of Tuya’s customers, among others, which included, among other things, exposing 13 million records of fake reviews organized scams linked to more than 200,000 Amazon account profiles; (3) that due to the above, there was a substantial risk that a significant portion of Tuya’s important customers would not be permitted to use Amazon.com’s platform, which would adversely impact Tuya’s business, revenues, profits and prospects; and (4) as a result, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis at all relevant times.

LifeStance Health Group, Inc. (LFST)
Course period: June 7, 2021 – August 10, 2022
Lead Applicant Deadline: October 11, 2022

The complaint filed in this class action alleges that the defendants made materially false and/or misleading statements, and failed to disclose material adverse facts regarding the company’s business, operations and prospects. Specifically, the defendants failed to disclose to investors: (1) that the number of virtual visits clients undertook using LifeStance declined as COVID-19 related lockdowns were lifted, capping outpatient revenue growth /virtuals of the company; (2) that the percentage of in-person visits customers were undertaking using LifeStance increased as COVID-19 lockdowns were lifted, resulting in a substantial increase in the Company’s operating expenses; (3) that LifeStance had lost a large number of physicians to burnout and as a result its physician retention rate had fallen significantly below the 87% stated in the registration statement and the company had engaged additional costs to integrate new physicians who were less productive than the outgoing physicians they replaced; and (4) as a result, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis at all relevant times.

MINISO Holding Group Limited (: MNSO)
Course period: October 12, 2020 – August 17, 2022
Lead Applicant Deadline: October 17, 2022

The complaint filed in this class action alleges that the defendants made materially false and/or misleading statements, and failed to disclose material adverse facts regarding the company’s business, operations and prospects. Specifically, defendants failed to disclose to investors that: (1) defendants and other undisclosed related parties owned and controlled a significantly larger number of MINISO stores than previously disclosed; (2) as a result, MINISO concealed its true costs; (3) the Company has not represented its true business model; (4) Defendants, including the company and its president, engaged in unusual and unclear planned transactions; (5) as a result of at least one of these transactions, the Company may breach contracts with the authorities of the PRC; (6) the Company would imminently and drastically reduce its franchise fees; and (7) therefore, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis at all relevant times.

Ampio Pharmaceuticals, Inc. (: AMPE)
Course period: December 29, 2020 – August 3, 2022
Lead Applicant Deadline: October 17, 2022

The Complaint filed in this Class Action alleges that throughout the Class Period, the Defendants made materially false and/or misleading statements, and failed to disclose material adverse facts regarding the business, operations and societal prospects. Specifically, the defendants: (1) inflated the company’s true ability to successfully file a BLA for Ampion; (2) inflated the results of the AP-013 study and the timing of the unblinding of the AP-013 study data; and (3) as a result, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

To be a member of these class actions, you do not need to act at this time; you can retain the services of a lawyer of your choice or do nothing and remain an absentee member of the class action. If you would like to know more about these class action lawsuits, or if you have any questions regarding this announcement or your rights or interests in these matters, please contact Frank R. Cruz, The Law Offices of Frank R. Cruz , 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067 at 310-914-5007, by e-mail at [email protected], or visit our website at www.frankcruzlaw.com. If requesting by email, please include your mailing address, phone number and number of shares purchased.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethics rules.

contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
[email protected]
www.frankcruzlaw.com

The-Law-Firms-of-Frank-R-Cru.png

Share.

Comments are closed.